Innophore GmbH

Private

GrazHealthcare & Life Scienceshttps://innophore.com/

Total Funding Raised

$2,100

Company Overview

Innophore GmbH is a biotechnology company that provides an AI-driven enzyme discovery and drug-safety screening platform for the pharmaceutical, chemical, and food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

biocatalysisprotein engineeringstructural bioinformaticsenzyme discoveryin silico screeningAI drug discoverybiotech R&Denzyme optimizationprotein designcomputational biologycontract researchCRObiotech SaaSgreen chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Innophore GmbH Comparables

Compare Innophore GmbH with similar companies based on industry and business-model similarity.

Innophore GmbH comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Imperagen	88%
Zymvol Biomodeling	86%
Biomatter	83%

View all Comparables

Innophore GmbH Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Christoph Blaschitz

Co-Founder and CFO

Founding Team

Georg Steinkellner

CTO, co-Founder, co-Managing Director

Founding Team

Christian C. Gruber

Co-Founder & CEO

Founding Team

Bettina Nestl

Chief Operating Officer

Executive Team

View all key people

Innophore GmbH Investors

Notable investors and investment history

Innophore GmbH investors
Investor	Rounds
Steirische Wirtschaftsförderungsgesellschaft	Grant, Accelerator
EOSS Industries	Accelerator
Science Park Graz	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 10, 2025
Monthly visitors increased 133% MoM, reaching 2.8K.
Oct 29, 2024
Monthly visitors increased 457% MoM, reaching 479.

View all signals

Innophore GmbH Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Innophore GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Innophore GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersGraz

Employee Range20

Year Founded2017

Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.